USPTO serial 78658566
NANOTOX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DAHLING, KRISTIN M
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NANOTOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tamsen V. Valoir
Willam J. Stahl nanoTox, Inc.P.O. Box 1548Austin, TX 78767UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for scientific research purposes, namely, tissues or cell lines for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; proteins, peptides, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical test kits containing tissues, cell lines, proteins, peptides, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific analysis purposes, namely, reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; test kits containing chemical reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical formulations for the solubilization, stabilization, or activation of nanoscale materials for use in presentation of nanoscale materials to various biological, physical, or chemical test systems to facilitate identification or assessment of nanoscale materials or biological interactions with nanoscale materials; diagnostic preparations for scientific use | ACTIVE | — |
| 005 | Biological preparations for toxicologic and pharmacologic analysis purposes; chemical preparations for toxicological evaluation of nanomaterials and nanodevices; nanomaterial preparations for medical use; diagnostic preparations for medical use | ACTIVE | — |
| 009 | Scientific apparatus, instruments and devices for research and examination purposes, namely, lab-on-a-chip devices for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; gene microarrays for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; biosensors using chemical, electrochemical, biochemical, enzymatic, chromatographic, spectroscopic, or mass spectral detection methods for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; computers programmed with relational or expert databases of nanoscale material identification or assessment information for use in identification or assessment of nanoscale materials or biological interactions with nanoscale materials; laboratory equipment, measuring apparatus and instruments, namely, nanoscale material generation systems for introduction of nanoscale materials into physical, chemical, biochemical, or biological test systems comprised of dust generators for generating in vitro and in vivo exposures to nanoparticulates for inhalation exposures at toxicologic, pharmacologic, or therapeutic airborne concentrations, vaporizers, nebulizers and sprayers all for use in generating in vitro and in vivo exposures to droplets and other particles containing nanomaterials for inhalation exposures at toxicologic, pharmacologic or therapeutic concentrations, mixers for preparing test materials in solution, semi-solids or solids for exposures or doses of nanomaterials in vitro or in vivo experimental tests of a biological or clinical nature, incubators for creating and maintaining controlled test environments; pipettors, syringes and containers and containment devices designed to retain, and deliver nanomaterials in liquid, semi-solid or solid dosage forms and for chemical analysis of dosage forms and biological samples from toxicologic or pharmacologic exposures in vitro and in vivo, and microplates designed to contain nanomaterials to avoid physicochemical, chemical, physical or electromagnetic effects that would interfere with precise measurements of toxicologic or pharmacologic endpoints; photometric test systems for use in the identification or assessment of nanoscale materials comprised of microplate readers, photomicroscopes, uv/vis photometers and photometric detectors, infrared photometers, photometric detectors, x-ray, gamma-ray, photo fluorescence and magnetic resonance imaging equipment; environmental sampling devices or systems for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials comprised of dust and particulate impact collectors, electrostatic precipitators, water filtration collectors, centrifugal collection devices, air filtration devices and collectors, size exclusion separators, mass spectrometric air sampling systems comprised of mass selective or multiple detectors; photometric air and water sampling systems comprised of air or water sampling chambers with infrared, visible, ultraviolet, fluorescent or laser photometric means of nanoparticulate detection, x-ray diffraction and x-ray fluorescence sampling systems comprised of a variable x-ray source, nanomaterials containment or targeting device and an x-ray detector, liquid and chromatographic sampling systems comprised of an electronically or hydraulically controlled liquid sampling loop to deliver nanomaterials and a microprocessor-controlled microplate or vial in rack-type sample collector | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by nanoLife Sciences, Inc.
- Other trademarks owned by nanoLife Sciences, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named NANOTOX
- Prosecution event ARAA explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 17, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 17, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 10, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 10, 2009 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 5, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 15, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 15, 2009 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 15, 2009 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 15, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 15, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 15, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 15, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 14, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 14, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 14, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2008 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 15, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 20, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 4, 2008 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jan 29, 2008 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 29, 2008 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 24, 2008 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jan 24, 2008 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 4, 2007 | PAPER RECEIVED | — | |
| Sep 17, 2007 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 21, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 14, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 12, 2007 | ALIE | ASSIGNED TO LIE | — |
| Apr 25, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2007 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 24, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 24, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 19, 2007 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 19, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 19, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2007 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 19, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2007 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 19, 2007 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jan 18, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 18, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 19, 2006 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 19, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 11, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2005 | NWAP | NEW APPLICATION ENTERED | — |